Zymeworks Inc.
ZYME · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0.4% | -81.6% | 1,446% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 100% | -88.1% | 100% | 100% |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -142.4% | -158.8% | 34.5% | -772.4% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -160.8% | -156.1% | 30.1% | -794% |
| EPS Diluted | -1.62 | -1.72 | 1.9 | -4.06 |
| % Growth | 5.8% | -190.5% | 146.8% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |